Blood Transfusion Research Revolutionizes Heart Attack Treatment Standards

Acclaimed internist Jeffrey Carson, a distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, has spent decades persuading hospitals that fewer blood transfusions work as well as more frequent ones for most patients. His groundbreaking research has established a new standard for treating anemic heart attack patients, indicating that more frequent transfusions can save lives. The Association for the Advancement of Blood & Biotherapies (AABB), along with the American College of Cardiology and the American Heart Association, has updated their guidelines to recommend giving more transfusions to patients suffering from myocardial infarction, keeping their blood hemoglobin levels near 10 grams per deciliter.

Key Takeaways:

  • Jeffrey Carson's research, published in late 2023 in the New England Journal of Medicine, found that anemic heart attack patients should receive more frequent blood transfusions to maintain a higher hemoglobin level.
  • A combined analysis of patients from several studies indicates that this approach can prevent 4,800 recurrent attacks or deaths and 3,200 deaths annually, requiring an extra 366,000 pints of blood.
  • Carson's work has been influenced by his studies on Jehovah's Witness patients who refused blood transfusions on religious grounds, which led to the establishment of two key facts: 1) most patients fare well with hemoglobin levels of 7-8 grams per deciliter, and 2) people with serious heart problems fare better with higher hemoglobin levels.
  • Carson's research has changed clinical medicine twice in the past 25 years, first by reducing blood transfusions and now by advocating for more frequent transfusions in specific cases.
  • The new guidelines are the first to break from more restrictive transfusion recommendations, urging fewer transfusions that keep hemoglobin at 7-8 grams per deciliter for all anemic patients.

Statistics:

  • Estimates suggest that each year, about 200,000 Americans who suffer heart attacks also have anemia (low levels of hemoglobin).
  • Carson's study found that adopting a liberal strategy (giving more blood to maintain a higher hemoglobin level) could prevent 4,800 recurrent attacks or deaths and 3,200 deaths annually.
  • The new guidelines require an extra 366,000 pints of blood, slightly more than 3% of the 10 million transfused nationwide each year.
  • The largest and most definitive study, the Myocardial Ischemia and Transfusion trial, randomized 3,504 heart-attack patients between 2017 and 2023, with 144 hospitals on five continents.
  • At 30 days, 14.5% of liberal-strategy patients had died or suffered another heart attack, compared with 16.9% in the restrictive group.
  • The pooled analysis of 4,311 patients found that restrictive care was linked to a 47% higher risk of cardiac death at 30 days and a modest but significant rise in six-month all-cause mortality.

Sources:

  • Rutgers University, "How a Doctor's Blood Transfusion Research Is Changing Standards and Saving Lives"
  • New England Journal of Medicine, late 2023
  • Association for the Advancement of Blood & Biotherapies (AABB)
  • American College of Cardiology
  • American Heart Association
  • Lancet, 1996
  • FOCUS trial, 2011
  • National Institutes of Health (NIH)
  • Johns Hopkins University School of Medicine
  • University of Pittsburgh
  • New York University